Preoperative serum prostate-specific antigen (PSA) below 10 μg/l predicts neither the presence of prostate cancer nor the rate of postoperative PSA failure

Clinical Chemistry

Volumn 47, Issue 4, 2001, Pages 631-634

  Stamey, T A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER GRADING; CANCER MORTALITY; HUMAN; PREDICTION; PREOPERATIVE EVALUATION; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVIEW;

EID: 0035058774     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.4.631     Document Type: Review

References (17)

1. Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: Implications for point-of-care testing
2. Physiological variation of serum prostate specific antigen (PSA) in the 4.0-10.0 ng/ml range in male volunteers
3. Latent carcinoma of the prostate
4. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer
5. Latency and progression in tumours: The natural history of prostate cancer
6. The frequency of carcinoma and intraepithetial neoplasia of the prostate in young male patients
7. Carcinoma of the prostate in men 80 or more years old
8. The epidemiology of prostate cancer part I: Descriptive epidemiology
9. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate
10. Prostate cancer is highly predictable: A prognostic equation based on all morphological variables in radical prostatectomy specimens
11. Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis
12. Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: Relationship to transition zone volume
13. Biological determinants of cancer progression in men with prostate cancer
14. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: Results of a prospective clinical trial
15. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate